Gilead Sciences, Inc. (GILD)
129.58
-2.48
(-1.88%)
USD |
NASDAQ |
May 15, 16:00
129.69
+0.11
(+0.08%)
After-Hours: 20:00
Gilead Sciences Total Assets (Quarterly) : 56.28B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 92.50B |
| Biogen, Inc. | 29.48B |
| AbbVie, Inc. | 136.46B |
| Moderna, Inc. | 11.49B |
| Abbott Laboratories | 110.43B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 32.85B |
| Shareholders Equity (Quarterly) | 23.52B |
| Debt to Equity Ratio | 0.943 |
| Current Ratio | 1.967 |
| Net Debt Paydown Yield | 0.59% |